SCHEMBL6154891

SCHEMBL6154891

CC(C)(O)CCCCc1ccc(/C=C/c2ccc(CO)c(O)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.39
BCHE P06276 2/20 0.38
SPHK1 Q9NYA1 2/20 0.35
SPHK2 Q9NRA0 1/20 0.35
ALOX5 P09917 1/20 0.35
ESR1 P03372 1/20 0.35
CYP19A1 P11511 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP24A1 Q07973 2/20 0.34
VDR P11473 1/20 0.34
MET P08581 2/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
LCK P06239 2/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
NQO2 P16083 1/20 0.33
IAPP P10997 1/20 0.33
IGF1R P08069 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154895 1.00 HMGCR (0.39) HMGCRBCHESPHK1SPHK2ALOX5
SCHEMBL6155141 0.90 MMP2 (0.43) HMGCRSPHK1SPHK2ALOX5CYP24A1
SCHEMBL6155147 0.90 MMP2 (0.43) HMGCRSPHK1SPHK2ALOX5CYP24A1
SCHEMBL6155531 0.90 HMGCR (0.41) HMGCRSPHK1SPHK2ALOX5CYP24A1
SCHEMBL6155533 0.90 HMGCR (0.41) HMGCRSPHK1SPHK2ALOX5CYP24A1
SCHEMBL6155863 0.89 MMP2 (0.42) HMGCRBCHESPHK1SPHK2ALOX5
SCHEMBL6155861 0.89 MMP2 (0.42) HMGCRBCHESPHK1SPHK2ALOX5
SCHEMBL2107463 0.88 HMGCR (0.40) HMGCRBCHESPHK1SPHK2CYP24A1
SCHEMBL2107466 0.88 HMGCR (0.40) HMGCRBCHESPHK1SPHK2CYP24A1
SCHEMBL27557366 0.84 BCHE (0.47) BCHEESR1CYP19A1ESR2PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124779-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2005-02-02 EP claimed
US-6689922-B1 BIAROMATIC COMPOUNDS WHICH ARE ANALOGUES OF VITAMIN D HAVE A MARKED ACTIVITY IN THE FIELDS OF CELL DIFFERENTIATION AND PROLIFERATION GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) 2004-02-10 US claimed
EP-2879656-B2 DYE COMPOSITION IN CREAM FORM COMPRISING AT LEAST ONE OIL AND LITTLE OR NO SOLID FATTY ALCOHOL, DYEING PROCESS AND SUITABLE DEVICE OREAL (FR) 2024-07-17 EP disclosed
EP-2879649-B2 DYEING COMPOSITION COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE OXIDIZING AGENT AND AT LEAST ONE NON-IONIC, ANIONIC AND AMPHOTERIC SURFACTANT OREAL (FR) 2022-08-24 EP disclosed
EP-2879656-B1 DYE COMPOSITION IN CREAM FORM COMPRISING AT LEAST ONE OIL AND LITTLE OR NO SOLID FATTY ALCOHOL, DYEING PROCESS AND SUITABLE DEVICE OREAL (FR) 2019-05-29 EP disclosed
US-10226411-B2 Dyeing composition comprising a fatty substance, a non-ionic guar gum, an amphoteric surfactant and a non-ionic or anionic surfactant, and an oxidizing agent, dyeing process and suitable device L'OREAL (FR) 2019-03-12 US disclosed
US-10201483-B2 Dye composition in cream form comprising at least one oil and little or no solid fatty alcohol, dyeing process and suitable device L'OREAL (FR) 2019-02-12 US disclosed
EP-2879649-B1 DYEING COMPOSITION COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE OXIDIZING AGENT AND AT LEAST ONE NON-IONIC, ANIONIC AND AMPHOTERIC SURFACTANT OREAL (FR) 2018-11-07 EP disclosed
US-9827185-B2 Dyeing composition comprising at least one fatty substance, at least one oxidizing agent and at least one non-ionic, anionic and amphoteric surfactant L'OREAL (FR) 2017-11-28 US disclosed
EP-2879650-B1 DYEING COMPOSITION COMPRISING A FATTY SUBSTANCE, A NON-IONIC GUAR GUM, AN AMPHOTERIC SURFACTANT AND A NON-IONIC OR ANIONIC SURFACTANT, AND AN OXIDIZING AGENT, DYEING PROCESS AND SUITABLE DEVICE OREAL (FR) 2017-07-26 EP disclosed
US-20150257993-A1 DYEING COMPOSITION COMPRISING A FATTY SUBSTANCE, A NON-IONIC GUAR GUM, AN AMPHOTERIC SURFACTANT AND A NON-IONIC OR ANIONIC SURFACTANT, AND AN OXIDIZING AGENT, DYEING PROCESS AND SUITABLE DEVICE L'OREAL (FR) 2015-09-17 US disclosed
WO-2014020167-A2 DYE COMPOSITION COMPRISING AT LEAST ONE SULFONIC COMPOUND AND A THICKENING POLYMER, DYEING PROCESS AND SUITABLE DEVICE L'OREAL (FR) 2014-02-06 WO disclosed
WO-2014020146-A2 DYEING COMPOSITION COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE OXIDIZING AGENT AND AT LEAST ONE NON-IONIC, ANIONIC AND AMPHOTERIC SURFACTANT L'OREAL (FR) 2014-02-06 WO disclosed
US-20050169945-A1 Composition for protecting keratin material, process of making, uses thereof L'OREAL (FR) 2005-08-04 US disclosed
EP-1559398-A1 Process for preparing a composition for the cosmetic treatment of keratinous materials on the basis of a pressurised fluid and vitamins L'OREAL (FR) 2005-08-03 EP disclosed
EP-1124779-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2005-02-02 EP disclosed
US-6689922-B1 BIAROMATIC COMPOUNDS WHICH ARE ANALOGUES OF VITAMIN D HAVE A MARKED ACTIVITY IN THE FIELDS OF CELL DIFFERENTIATION AND PROLIFERATION GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) 2004-02-10 US disclosed
EP-1262168-A1 Composition containing fibres to combat the skin aging process L'OREAL (FR) 2002-12-04 EP disclosed
EP-1124779-A1 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2001-08-22 EP disclosed
WO-2000026167-A1 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2000-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10226411-B2 Dyeing composition comprising a fatty substance, a non-ionic guar gum, an amphoteric surfactant and a non-ionic or anionic surfactant, and an oxidizing agent, dyeing process and suitable device KRT18, OAT, DSG1 HMGCR 1759/4885BCHE 2477/4885SPHK1 1312/4885
US-10201483-B2 Dye composition in cream form comprising at least one oil and little or no solid fatty alcohol, dyeing process and suitable device KRT18, CUTA, DSG1 HMGCR 844/4885BCHE 3171/4885SPHK1 1100/4885
US-20150257993-A1 DYEING COMPOSITION COMPRISING A FATTY SUBSTANCE, A NON-IONIC GUAR GUM, AN AMPHOTERIC SURFACTANT AND A NON-IONIC OR ANIONIC SURFACTANT, AND AN OXIDIZING AGENT, DYEING PROCESS AND SUITABLE DEVICE KRT18, OAT, DSG1 HMGCR 1638/4885BCHE 2458/4885SPHK1 1387/4885
US-20050169945-A1 Composition for protecting keratin material, process of making, uses thereof KRT18, PROC, CUTA HMGCR 1113/4885BCHE 3346/4885SPHK1 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.